CMChristina Megli

Christina Megli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christina Megli has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Placental Pathogens Associated With Adverse Maternal and Neonatal Outcomes

    by Alicia Liu, Caitlin Little, Talia Dubowitz, Malinda Schaeffer, Lauren Skvarca, Anne-Marie Rick, Thomas Hooven, Michael Morowitz, Sharon L Hillier, Harold C Wiesenfeld, et al.

    Background: Bacterial infection at the maternal-fetal interface contributes to adverse pregnancy outcomes, including preterm birth, chorioamnionitis, and sepsis. Despite evolving obstetric practices that may influence microbial patterns, recommended clinical algorithms for prophylaxis and treatment rely on outdated data. Furthermore, the pathogenic organisms associated with adverse outcomes remain incompletely characterized. Methods: We conducted a retrospective study of placental cultures from a high-risk obstetric cohort from a single hospital system between 2014 and 2019 (n = 714). Placental cultures were obtained from deliveries at high risk for infection: (eg, preterm birth or suspected chorioamnionitis). Placental cultures were stratified into pathogenic and nonpathogenic. Associated clinical outcomes, histopathology, and antimicrobial susceptibility patterns were compared. Results: Pathogenic organisms were identified in 69% of cultures (492 of 714). Group B Streptococcus (n = 161; 22.5% of total isolates) and Escherichia coli (n = 53; 7.4% of total isolates) were the most common pathogens isolated; we also identified additional pathogens, including Enterococcus faecalis (n = 44), Haemophilus (n = 37), Prevotella (n = 32), and Bacteroides species (n = 23). Pathogenic cultures were correlated with significantly higher rates of composite adverse maternal (27.0% vs 17.6%; P = .006) and neonatal (78.9% vs 60.6%; P < .001) outcomes, as well as histopathologic chorioamnionitis (72.5% vs 60.9%; P = .003). Antimicrobial resistance for recommended empiric regimens ranged from 47.1% to 87.8%. Conclusions: Bacterial pathogens isolated from the placenta in high-risk pregnancies are associated with perinatal morbidity. Group B Streptococcus and E coli remain common, and E faecalis, Haemophilus spp, and anaerobes such as Prevotella may represent emerging pathogens underrecognized in contemporary obstetric practice. Placental cultures may serve as a valuable surveillance tool for informing empiric antibiotic strategies in pregnancy.

  • ALARA in Antimicrobial Stewardship: Adapting Radiation Safety Principles to Address Antibiotic Overuse

    by Zachary T Aldewereld, Christina J Megli, Adam C Olson, Michael J Morowitz

    Despite decades of antimicrobial stewardship programs, antibiotic overuse persists due to imprecise guidelines relying on subjective terms such as “optimal” and “appropriate” use. Current stewardship approaches lack a unifying communication framework that effectively bridges technical recommendations with real-world prescribing decisions across medical specialties. We propose adapting ALARA (As Low As Reasonably Achievable) from radiation safety as a transformative framework for antibiotic stewardship. Like radiation, antibiotics provide indisputable benefits while carrying hidden cumulative costs—including microbiome disruption, immune dysfunction, and increased mortality in specific populations. ALARA's three pillars (justification, optimization, and dose limitation) map directly to antimicrobial stewardship needs and could standardize prescribing approaches across specialties. This framework addresses the distributed nature of antibiotic prescribing by providing clear principles that transcend subjective judgments. By treating antibiotics as beneficial but inherently risky interventions requiring careful justification, ALARA could reduce unnecessary exposure while maintaining efficacy, ultimately improving both patient outcomes and global antimicrobial resistance patterns.


  • Open Access

    Oropouche virus infects human trophoblasts and placenta explants

    by Christina J. Megli, Rebecca K. Zack, Jackson J. McGaughey, Ryan M. Hoehl, Taylor Snisky, Amy L. Hartman, Cynthia M. McMillen

    Clinical and epidemiologic evidence from the 2023–24 outbreak of Oropouche virus (OROV) has demonstrated increased severity in clinical disease and adverse pregnancy outcomes including miscarriage, stillbirth, and neonatal demise. Serological evidence suggests vertical transmission of OROV may be responsible. OROV has not been studied in the context of pregnancy and has an unknown ability to infect the relevant tissues of the maternal-fetal interface; therefore, the mechanisms of vertical transmission are unknown. We use human cytotrophoblast and syncytiotrophoblast stem cell cultures, polarized trophoblast stem cell organoids, and placenta explants to demonstrate that OROV (BeAn19991) infects and replicates in human tissues of the maternal-fetal interface including cytotrophoblasts and the microbial-resistant cell, syncytiotrophoblast. Viral replication is robust within the first 24 hour post infection and infection may be dependent on gestational age. These data indicate tissues at the maternal-fetal interface are susceptible to OROV infection and may facilitate vertical transmission, leading to adverse pregnancy outcomes.


  • Top Cited Papers
    Open Access

    Virulence and pathogenicity of group B Streptococcus : Virulence factors and their roles in perinatal infection

    by Christina J. Megli, Sophia M. Carlin, Elizabeth J. Giacobe, Gideon H. Hillebrand, Thomas A. Hooven

    This review summarizes key virulence factors associated with group B Streptococcus (GBS), a significant pathogen particularly affecting pregnant women, fetuses, and infants. Beginning with an introduction to the historical transition of GBS from a zoonotic pathogen to a prominent cause of human infections, particularly in the perinatal period, the review describes major disease manifestations caused by GBS, including sepsis, meningitis, chorioamnionitis, pneumonia, and others, linking each to specific virulence mechanisms. A detailed exploration of the genetic basis for GBS pathogenicity follows, emphasizing the roles of capsules in pathogenesis and immune evasion. The paper also examines the molecular structures and functions of key GBS surface proteins, such as pili, serine-rich repeat proteins, and fibrinogen-binding proteins, which facilitate colonization and disease. Additionally, the review discusses the significance of environmental sensing and response systems, like the two-component systems, in adapting GBS to different host environments. We conclude by addressing current efforts in vaccine development, underscoring the need for effective prevention strategies against this pervasive pathogen.


  • Open Access

    Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface

    by Cynthia M. McMillen, Christina Megli, Rebecca Radisic, Lauren B. Skvarca, Ryan M. Hoehl, Devin A. Boyles, Jackson J. McGaughey, Brian H. Bird, Anita K. McElroy, Amy L. Hartman

    Rift Valley fever virus (RVFV) infection causes abortions in ruminant livestock and is associated with an increased likelihood of miscarriages in women. Using sheep and human placenta explant cultures, we sought to identify tissues at the maternal-fetal interface targeted by RVFV. Sheep villi and fetal membranes were highly permissive to RVFV infection resulting in markedly higher virus titers than human cultures. Sheep cultures were most permissive to wild-type RVFV and ΔNSm infection, while live attenuated RVFV vaccines (LAVs; MP-12, ΔNSs, and ΔNSs/ΔNSm) exhibited reduced replication. The human fetal membrane restricted wild-type and LAV replication, and when infection occurred, it was prominent in the maternal-facing side. Type-I and type-III interferons were induced in human villi exposed to LAVs lacking the NSs protein. This study supports the use of sheep and human placenta explants to understand vertical transmission of RVFV in mammals and whether LAVs are attenuated at the maternal-fetal interface. Teaser Vaccine strains of Rift Valley fever virus have reduced infection and replication capacity in mammalian placenta

  • Open Access

    Diet influences community dynamics following vaginal group B Streptococcus colonization

    by Christina J. Megli, Allison E. DePuyt, Julie P. Goff, Sarah K. Munyoki, Thomas A. Hooven, Eldin Jašarević

    The vaginal microbiota plays a pivotal role in reproductive, sexual, and perinatal health and disease. Unlike the well-established connections between diet, metabolism, and the intestinal microbiota, parallel mechanisms influencing the vaginal microbiota and pathogen colonization remain overlooked. In this study, we combine a mouse model of Streptococcus agalactiae strain COH1 (GBS) vaginal colonization with a mouse model of pubertal-onset obesity to assess diet as a determinant of vaginal microbiota composition and its role in colonization resistance. We leveraged culture-dependent assessment of GBS clearance and culture-independent, sequencing-based reconstruction of the vaginal microbiota in relation to diet, obesity, glucose tolerance, and microbial dynamics across time scales. Our findings demonstrate that excessive body weight gain and glucose intolerance are not associated with vaginal GBS density or timing of clearance. Diets high in fat and low in soluble fiber are associated with vaginal GBS persistence, and changes in vaginal microbiota structure and composition due to diet contribute to GBS clearance patterns in nonpregnant mice. These findings underscore a critical need for studies on diet as a key determinant of vaginal microbiota composition and its relevance to reproductive and perinatal outcomes. IMPORTANCE This work sheds light on diet as a key determinant influencing the composition of vaginal microbiota and its involvement in group B Streptococcus (GBS) colonization in a mouse model. The study shows that dietary components, such as dietary fat and soluble fiber, impact GBS density and timing of clearance in the female reproductive tract. These findings are particularly significant given clear links between GBS and adverse reproductive and neonatal outcomes, advancing our understanding by identifying critical connections between dietary components, factors originating from the intestinal tract, vaginal microbiota, and reproductive outcomes.

  • Open Access

    Disruption of maternal IgA by prenatal antibiotics precedes intestinal E. coli colonization and late-onset sepsis in neonates

    by Katya McDonald, Danielle Browning, Kara G. Greenfield, Kathryn Lin, Josephine Meier, Matthew Butoryak, Alexandria Sasaki, Eva Fandozzi, Tim Hand, Christina Megli, et al.

    Neonates, particularly prematurely born neonates, are particularly vulnerable to enteric pathogens. Antibiotics are widely administered during pregnancy for off-label use and prevention, but the effect on neonatal physiology has not been well characterized. Maternally derived IgA provided in milk is a predominant protective measure in the intestinal lumen of the nursing offspring. The connection between the maternal intestine and mammary IgA responses has been observed, but understanding how clinical use of antibiotics effects mammary IgA remains unclear. Here we find that prenatal cephalosporin antibiotics, but not penicillins, decrease mammary IgA in dams, and limit the availability of IgA within the lumen of nursing offspring. Decreased IgA correlated with an outgrowth of commensal E. coli and increased colonization and translocation of pathogen E. coli. Moreover, antenatal cephalosporin administration was associated with increased mortality in a model of LOS that was associated with decreased mammary IgA. Futhermore, in a clinical cohort of at-risk infants, maternal broad spectrum antibiotic treatment, including cephalosporins, increased the risk of LOS in neonates in comparison to penicillin-based treatments. This was associated with reduced IgA in the milk, and we propose maternal administration of select antibiotics could disrupt mammary IgA, leading to increased risk of LOS in infants by allowing for pathogen colonization in the neonatal intestine.


  • Open Access

    Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy

    by Erin K. McCreary, Lara Lemon, Christina Megli, Amber Oakes, Md Christopher W. Seymour, UPMC Magee Monoclonal Antibody Treatment Group*

    Randomized controlled trials of monoclonal antibodies (mAbs) for the treatment of COVID-19 excluded pregnant persons. A retrospective, propensity score–matched, cohort study was conducted in a larg... Visual Monoclonal Antibody Treatment in Pregnancy. Randomized controlled trials of monoclonal antibodies (mAbs) for the treatment of COVID-19 excluded pregnant persons. A retrospective, pr... Background: Monoclonal antibody (mAb) treatment decreases hospitalization and death in high-risk outpatients with mild to moderate COVID-19. However, no studies have evaluated adverse events and ef...


  • Open Access

    Nitric Oxide Production and Effects in Group B Streptococcus Chorioamnionitis

    by Mary Frances Keith, Kathyayini Parlakoti Gopalakrishna, Venkata Hemanjani Bhavana, Gideon Hayden Hillebrand, Jordan Lynn Elder, Christina Joann Megli, Yoel Sadovsky, Thomas Alexander Hooven

    Intrauterine infection, or chorioamnionitis, due to group B Streptococcus (GBS) is a common cause of miscarriage and preterm birth. To cause chorioamnionitis, GBS must bypass maternal-fetal innate immune defenses including nitric oxide (NO), a microbicidal gas produced by nitric oxide synthases (NOS). This study examined placental NO production and its role in host-pathogen interactions in GBS chorioamnionitis. In a murine model of ascending GBS chorioamnionitis, placental NOS isoform expression quantified by RT-qPCR revealed a four-fold expression increase in inducible NOS, no significant change in expression of endothelial NOS, and decreased expression of neuronal NOS. These NOS expression results were recapitulated ex vivo in freshly collected human placental samples that were co-incubated with GBS. Immunohistochemistry of wild type C57BL/6 murine placentas with GBS chorioamnionitis demonstrated diffuse inducible NOS expression with high-expression foci in the junctional zone and areas of abscess. Pregnancy outcomes between wild type and inducible NOS-deficient mice did not differ significantly although wild type dams had a trend toward more frequent preterm delivery. We also identified possible molecular mechanisms that GBS uses to survive in a NO-rich environment. In vitro exposure of GBS to NO resulted in dose-dependent growth inhibition that varied by serovar. RNA-seq on two GBS strains with distinct NO resistance phenotypes revealed that both GBS strains shared several detoxification pathways that were differentially expressed during NO exposure. These results demonstrate that the placental immune response to GBS chorioamnionitis includes induced NO production and indicate that GBS activates conserved stress pathways in response to NO exposure.


  • Vancomycin and Piperacillin-tazobactam Use in Obstetric Patients is Associated with Renal Injury

    by Sharlay Butler, Selma Su, Christina Megli, Bennett Sarah, Ariel Trilling, Jourdan Schmitz